AnastasiosRaptisMD

PubMed

• A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.
  Redner, R. L., Beumer, J. H., Kropf, P., Agha, M., Boyiadzis, M., Dorritie, K., Farah, R., Hou, J., Im, A., Lim, S. H., Raptis, A., Sehgal, A., Christner, S. M., Normo...> ;Leukemia & lymphoma. 2018 Apr 5
• 2 citations
  Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.
  Boyiadzis, M., Agha, M., Redner, R. L., Sehgal, A., Im, A., Hou, J., Farah, R., Dorritie, K. A., Raptis, A., Lim, S. H., Wang, H., Lapteva, N., Mei, Z., Butterfield, L...> ;Cytotherapy. 2017 Sep 3
• Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation
  Konstantinos Lontos, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, James M. Rossetti...> ;Clinical Transplantation. 2017 Sep 1
• Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.
  Lim, M. J., Agha, A., Im, A., Raptis, A., Hou, J. Z., Boyiadzis, M., Sehgal, A. R., Redner, R. L., Dorritie, K., Marks, S. S., Agha, M. E., Lim, S. H.> ;Hematological oncology. 2017 Jul 1
• 3 citations
  Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
  Villgran, V., Agha, M., Raptis, A., Hou, J., Farah, R., Lim, S. H., Redner, R. L., Im, A., Sehgal, A., Dorritie, K. A., Kiss, J. E., Normolle, D. P., Boyiadzis, M.> ;Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2016 Oct 19
• ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemia.
  Bobbi Hartsock, Matthew J. Lim, Christine G. Roth, Nepheli Raptis, David Weber, Alison R. Sehgal, Michael Boyiadzis, Anastasios Raptis, Jing-Zhou Hou, Annie Im, Kathle...> ;Leukemia Research. 2016 Sep 1
• Hypomethylating Agents for Relapse after Allogeneic Hematopoietic Cell Transplantation in Myeloid Malignancies: A Case Series and Review of the Literature.
  Im A, Raptis A, Hou J, Tompkins C, Winfield M, Guay M, Boyiadzis M, Agha M> ;Acta Haematol.. 2016-01-01
• Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse.
  Im A, Amjad A, Agha M, Raptis A, Hou J, Farah R, Lim S, Sehgal A, Dorritie KA, Redner RL, McLaughlin B, Shuai Y, Duggal S, Boyiadzis M> ;Oncol. Res.. 2016-01-01
• Flow Cytometric Evaluation of Double/Triple Hit Lymphoma.
  Roth CG, Gillespie-Twardy A, Marks S, Agha M, Raptis A, Hou J, Farah R, Lin Y, Qian Y, Pantanowitz L, Boyiadzis M> ;Oncol. Res.. 2016-01-01
• Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant.
  Agha, A., Sehgal, A., Lim, M. J., Weber, D., Hou, J., Farah, R., Raptis, A., Im, A., Dorritie, K., Marks, S., Agha, M., Lim, S. H.> ;American journal of hematology. 2015 Dec 15
• Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy.
  Sara J. Lim, Matthew J. Lim, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Stanley M. Marks, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, Mounzer Agha, Raymond E...> ;American Journal of Hematology. 2015 Aug 1
• 2 citations
  IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant.
  Lim, M. J., Stebbings, A., Lim, S. J., Foor, K., Hou, J., Farah, R., Raptis, A., Marks, S., Weber, D., Im, A., Dorritie, K., Sehgal, A., Agha, M., Lim, S. H.> ;Bone marrow transplantation. 2015 Jun 9
• Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.
  Lim, S. J., Lim, M. J., Raptis, A., Hou, J., Farah, R., Marks, S., Im, A., Dorritie, K., Sehgal, A., Agha, M., Lim, S. H.> ;European journal of haematology. 2015 Mar 19
• 1 citation
  Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy.
  B. T. McLaughlin, Annie Im, Anastasios Raptis, Mounzer Agha, Jing-Zhou Hou, Robert L. Redner, Shrina Duggal, Yan Lin, Clay Smith, Michael Boyiadzis> ;International Journal of Hematology. 2012 Nov 7
• Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia.
  Strickland, S. A., Raptis, A., Hallquist, A., Rutledge, J., Chernick, M., Perree, M., Talbott, M. S., Presant, C. A.> ;Leukemia & lymphoma. 2012 Aug 29
• The Microculture-Kinetic (MiCK) Assay: The Role of a Drug-Induced Apoptosis Assay in Drug Development and Clinical Care
  Linda Bosserman, Franklyn G Prendergast, Roy S. Herbst, Martin Fleisher, Emery M. Salom, Steven Strickland, Anastasios Raptis, Allan Hallquist, Mathieu Perree, Swapnil...> ;Cancer Research. 2012 Aug 15
• 2 citations
  Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.
  Lieberman, F. S., Yazbeck, V., Raptis, A., Felgar, R. E., Boyiadzis, M.> ;Journal of neuro-oncology. 2011 Nov 1
• Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy.
  Michael Boyiadzis, Robert L. Redner, Anastasios Raptis, Jing-Zhou Hou, Mounzer Agha, Kenneth A. Foon> ;Annals of Hematology. 2011 Jun 1
• 1 citation
  Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy.
  Mehta, D. R., Foon, K. A., Redner, R. L., Raptis, A., Agha, M., Hou, J., Duggal, S., Luong, T., Schlesselman, J. J., Boyiadzis, M.> ;Leukemia research. 2011 Feb 15
• 2 citations
  Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with acute myeloid leukemia.
  McHayleh, W., Foon, K. A., Redner, R. L., Sehgal, R., Raptis, A., Agha, M., Luong, T., Schlesselman, J. J., Boyiadzis, M.> ;Cancer. 2010 Jun 22
• Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
  Raptis, A.,Duh, M. S.,Wang, S. T.,Dial, E.,Fanourgiakis, I.,Fortner, B.,Paley, C.,Mody-Patel, N.,Corral, M.,Scott, J.> ;Transfusion. 2009 Sep 02
• 2 citations
  Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin.
  Wassim McHayleh, Rajesh Sehgal, Robert L. Redner, Anastasios Raptis, Mounzer Agha, James J Natale, James J. Schlesselman, Kennteh A. Foon, Michael Boyiadzis> ;Leukemia & Lymphoma. 2009 Nov 3
• Etoposide and mitoxantrone in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy with cytarabine and idarubicin.
  McHayleh WM, Redner R, Sehgal R, Raptis A, Agha M, Natale J, Luong T, Schlesselman JJ, Foon K, Boyiadzis M> ;J. Clin. Oncol.. 2009-05-20
• 11 citations
  Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
  Foon, K. A., Boyiadzis, M., Land, S. R., Marks, S., Raptis, A., Pietragallo, L., Meisner, D., Laman, A., Sulecki, M., Butchko, A., Schaefer, P., Lenzer, D., Tarhini, A...> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Dec 17
• Treatment of transfusional iron overload (TIO) in patients with myelodysplastic syndrome (MDS).
  Raptis A, Duh MS, Weiner JR, Wang S, Fortner B, Mody-Patel N, Scott J> ;J. Clin. Oncol.. 2008-05-20
• Join now to see all